Related by context. All words. (Click for frequent words.) 52 PaO 2 49 hyperoxia 48 cm H2O 48 #OHD 48 Cardiopulmonary bypass 48 MADRS score 48 nmol liter 47 LVEF 47 hemoglobin Hb 47 AST ALT 47 reactive hyperemia 47 inotropic 47 TAPAS 47 periprocedural 46 mL kg 46 CI -#.# 46 serum IGF 46 ALT 46 serum albumin 46 angiotensin converting enzyme 46 hemodilution 46 serum cortisol 46 tirofiban 45 LPS induced 45 CONCLUSION 45 SENSITIVITY 45 tHcy 45 % Confidence Interval 45 Hb A1C 45 Ca2 + 45 vasopressor 45 peri procedural 45 urine albumin 45 β blockers 45 adiponectin concentrations 45 Thrombolysis 45 Resynchronization 45 elevated creatinine 45 serum sodium 44 HbA 1c 44 hypotension 44 diastolic velocity 44 leukocyte count 44 IMPLICATIONS 44 multivariable analysis 44 serum potassium 44 pretest probability 44 prognostic significance 44 P = .# 44 systolic velocity 44 Hb 44 PCWP 44 CEILING 44 USE YOUR 44 Patency 44 Systolic 44 adrenomedullin 44 thyroglobulin 44 cerebral perfusion 44 HRCT 44 ATV RTV 44 echocardiographic 44 Dyspnea 44 transaminases 44 serum HBV DNA 44 platelet reactivity 44 bosentan 44 Kaplan Meier analysis 44 oxyhemoglobin 44 plasma cortisol 44 -#.# ± [002] 44 FATTY 44 aspartate aminotransferase AST 44 Ejection Fraction 44 leukocytosis 44 serum ALT 44 ACTH 43 D dimer 43 coronary stenosis 43 MAXIMA 43 BALF 43 reflux esophagitis 43 antibody titers 43 p = .# [002] 43 cTnI 43 plasma pharmacokinetics 43 ECLS 43 HOMA IR 43 serum bilirubin 43 CONCISE 43 urinary excretion 43 serum retinol 43 Serum creatinine 43 intact parathyroid hormone 43 dyssynchrony 43 μmol L 43 atherosclerotic renal artery stenosis 43 r2 = 43 left ventricular LV 43 L PPDS 43 Reperfusion 43 CFQ R 43 intraocular pressure 43 aspartate aminotransferase 43 dose dependently 43 ABSTRACT 43 TIMP 1 43 PERV 43 logistic regression analysis 43 regression coefficient 43 plasma leptin 43 DEFER 43 intima media thickness 43 SGPT 43 EXPERIMENT 43 multivariate Cox 43 ^ Tc 43 glucocorticoid 43 CK MB 43 mmol L 43 1alpha 43 myeloperoxidase 42 eosinophilia 42 NT proBNP 42 PSA nadir 42 fasting insulin 42 LV hypertrophy 42 PUSHING THE 42 concomitant medications 42 mCi 42 SGOT 42 subscore 42 Cmax 42 nonfatal MI 42 radioligand 42 SCr 42 DOWNWARD 42 parenchymal 42 x ULN 42 Carotid 42 pmol L 42 VO 42 VT VF 42 mL/min/#.# m 2 42 = #.#-#.# 42 TNFalpha 42 % CI #.#-#.# [007] 42 mU 42 Assessment Scale 42 cortical activation 42 fluticasone propionate FP 42 tyrosine phosphorylation 42 EBMT criteria 42 ACh 42 lymphocyte counts 42 MORTALITY 42 inhibin 42 F FDG 42 logistic regression model 42 Brief Psychiatric 42 dehydroepiandrosterone sulfate 42 mIU L 42 ischemia driven 42 triglycerides TG 42 eosinophil count 42 baroreceptor 42 COMIN 42 glycated hemoglobin 42 myocardial contractility 42 intracellular Ca 2 42 systolic hypertension 42 SUVmax 42 RECIST 42 Abciximab 42 nitrotyrosine 42 pg ml 42 mol L 42 ‰ ¥ 42 LV ejection fraction 42 HEADLIGHTS 42 immunoreactivity 42 subscale scores 42 HbA1c levels 42 triiodothyronine 42 MDRD 42 Ranolazine 42 serum creatinine 42 aPTT 42 triglyceride TG 42 diffusion weighted 41 dose atorvastatin 41 FAINT 41 plasminogen activator inhibitor 41 posttreatment 41 fasting plasma 41 statistically significant p = 41 nonsignificant 41 liver histology 41 SHRINK 41 OUTCOMES 41 COMPRESSION 41 estimated GFR 41 NYHA functional class 41 S#A# [002] 41 IS VERY 41 periprocedural MI 41 tipranavir r 41 isoprostane 41 LOAD 41 PROACTIVE 41 HbA 1c levels 41 TRAINING FOR 41 EQ 5D 41 binary restenosis 41 eNOS 41 DHCA 41 thyrotropin 41 FOR CHANGE 41 LV dysfunction 41 OBJECTIVES 41 extensive metabolizers 41 CR CRu 41 perioperative complications 41 International Prostate Symptom 41 lumbar spine BMD 41 POISE 41 aortic calcification 41 NEW AGE 41 NO MORE EXCUSES 41 intraventricular 41 Acute Ischemic Stroke 41 preoperative PSA 41 mRNA expression 41 cardiac troponin 41 Atrial 41 NOT GETTING 41 eplerenone 41 PSQI 41 RASSF1A 41 CONSEQUENCE 41 % CI #.#-#.# [005] 41 HBeAg seroconversion 41 Low Density Lipoprotein Cholesterol 41 CORE OM 41 BLIP 41 Fasting Glucose 41 MMSE score 41 microvessel density 41 postop 41 tPSA 41 % CI #.#-#.# [001] 41 p = 41 IL 1ß 41 latanoprost 41 antithrombotic therapy 41 log# copies mL 41 #β estradiol 41 mITT population 41 Hcy 41 macrophage infiltration 41 cardiac troponin T 41 Echocardiographic 41 thromboembolism 41 Confidence Intervals 41 creatinine ratio 41 rheumatoid factor 41 serum urate 41 UNFIT FOR 41 STICH 41 serum antibodies 41 PAGING 41 CI #.#-#.# [001] 41 MOCK 41 Main Outcome Measure 41 myocardial perfusion 40 UNLOAD 40 Ventricular Tachycardia 40 univariate analysis 40 OLE 40 p = #.# [002] 40 rCBF 40 carotid IMT 40 EISNER 40 thyroid stimulating hormone TSH 40 TRUS 40 cholesterol LDL C 40 prostaglandin E 40 Postoperative 40 β blocker 40 Non Responders 40 ASSIGNMENT OF ERROR 40 RUNNING OUT OF 40 MBq 40 IPSS 40 % CI #.#-#.# [004] 40 ventricular myocardium 40 TIMP 40 -#.# mmol L 40 aminotransferases 40 CD4 + CD# 40 pharmacodynamic PD 40 interrater reliability 40 F FDG PET 40 microg 40 mRS 40 dose dexamethasone 40 CONCLUSIONS 40 QUANDARY 40 HORIZONTAL 40 albumin excretion rate 40 HIM UP 40 ATACAND 40 plasma lipid 40 elevated transaminases 40 CROCK 40 artery occlusion 40 HORIZONS 40 lymph node metastasis 40 adrenergic receptors 40 HEART FAILURE 40 #F FDG PET 40 serum triglycerides 40 statistical significance p 40 serum testosterone 40 QTc 40 STEINBECK 40 TOP2A 40 creatinine 40 mmHg diastolic 40 NIH CPSI 40 lactate dehydrogenase LDH 40 ST2 40 Quantitation 40 virologic response 40 creatine phosphokinase 40 YOU HAVE TO BE 40 GLUT 40 Score DAS# 40 EMISSION 40 triacylglycerol 40 apolipoprotein B 40 microalbuminuria 40 Rating Scale BPRS 40 ABSTRACTS 40 RLY 40 QTcF 40 mimetic peptide 40 PURPOSE 40 Hg 40 GOODBYE TO 40 renal artery stenosis 40 RENAL 40 urine NGAL 40 GORD 40 Lp PLA 2 40 tertiles 40 ß = 40 METHODS 40 ACCOMPLISH 40 #.#mmol L [002] 40 ω 40 elevated homocysteine 40 Pearson correlation coefficient 40 transgene expression 40 cAMP 40 PEG IFN 40 IgA 40 Metabolic Efficiency 40 biochemical relapse 40 serum lipid levels 40 QUEST FOR 40 μg liter 40 FUNCTIONAL 40 CHD 40 ^ sup #m 40 ertapenem 40 myocardial 40 NOSE 40 Myeloid 40 serologically active patients 40 GHRH 40 ONE FOOT 39 STRAT 39 mg dL 39 RBC transfusion 39 pg mL 39 fasting triglycerides 39 UNDERSTANDING THE 39 GEST 39 density lipoprotein cholesterol HDL 39 ENTITY 39 transaminase elevations 39 SGRQ 39 correlation coefficients 39 μg mL 39 THE MADNESS 39 CGRP 39 Db 39 hepatic glucose production 39 HT 1A 39 # NNNN 39 vasodilatory 39 platelet inhibitor 39 BEAT THE 39 SENSING 39 Ki# 39 Double Blind Randomized 39 mU liter 39 STENT 39 Kaplan Meier estimates 39 serum lactate 39 highest tertile 39 GOVERN 39 neutrophil count 39 Randomized Evaluation 39 ACCLAIM 39 Main Outcome Measures 39 PREVAIL 39 DEFINITIVE 39 distensibility 39 serum concentrations 39 DISTINCT 39 neoadjuvant chemotherapy 39 serum phosphate 39 glomerular 39 uM 39 ALT elevations 39 IL6 39 heterozygotes 39 echocardiographic parameters 39 p = #.# [003] 39 pCR 39 CLEAN WATER 39 P ≤ 39 OBJECTIVE 39 Kruskal Wallis test 39 PEDF 39 TESTER 39 leukotriene 39 r = 39 PROCEDURE 39 Ala Ala 39 hsCRP 39 lispro 39 lymphocyte count 39 elevated troponin 39 SOCIEDAD 39 BEHAVIORAL 39 TEST RESULTS 39 familial AF 39 SCROLL 39 ≥ 39 GFAP 39 THERE IS AN 39 THE DESTRUCTION OF 39 PSADT 39 #.#/#.# mmHg [001] 39 ultrasonography 39 peptide BNP 39 virological response 39 Predictive Value 39 cerebrovascular accident 39 RANK 39 Prolactin 39 Losartan Intervention 39 BACKGROUND AND 39 HF hospitalization 39 scintigraphic 39 multivariate adjustment 39 MID TERM 39 LDL cholesterol LDL 39 Comorbidity 39 ASSERT 39 Contrast Enhancement 39 Ventricular 39 E1 CLO 39 APPROXIMATE 39 paraprotein 39 CTEPH 39 obstructive CAD 39 multivariate analyzes 39 ON ARRIVAL 39 pyridoxal 5' phosphate 39 substudy 39 #m Tc 39 CAPRA 39 statistically significant p 39 isolated systolic hypertension 39 inflammatory biomarkers 39 mL/min/#.# m2 39 TEMP 39 CAUTIONS 39 PARM 39 fludarabine cyclophosphamide 39 perfusion abnormalities 39 elevated ALT 39 bivariate 39 reticulocyte 39 hs CRP 39 recurrent ischemic 39 AMISH 39 univariate analyzes 39 antitrypsin 39 EXTENDING THE 39 TRIGGER 39 atherogenic 39 ULORIC 39 ASST 39 fatal myocardial infarction 39 fibrin deposition 39 confidence interval CI 39 Implantable Defibrillator 39 Left Ventricular 39 SELENA SLEDAI 39 baseline FEV 39 LAMICTAL 39 symptomatic intracranial hemorrhage 39 CI #.#-#.# p = 39 Intraocular Pressure 39 hypogonadotropic hypogonadism 39 p ≤ 39 convergence insufficiency 39 GENES 39 adrenalectomy 39 placebo p = 39 Plasma concentrations 39 alanine aminotransferase 39 pneumonectomy 39 HGPIN 39 CR nPR 39 SF #v# 39 TROUGH 39 mean corpuscular volume 39 Prospective Randomized Trial 39 IFN beta 39 HDL C 38 creatine kinase 38 myocardial infarction 38 FDG uptake 38 Neutrophil 38 chloride secretion 38 muscarinic 38 T2DM 38 BREEDS 38 Secondary efficacy endpoints 38 serum homocysteine 38 creatine kinase MB 38 HABITS 38 glycated hemoglobin HbA1c 38 HALTS 38 subscores 38 recurrent VTE 38 PARAMETERS 38 splenocytes 38 GOUT 38 ApoB 38 IOP 38 alkaline phosphatase 38 % CI #.#-#.# [006] 38 ADJUSTING TO 38 atorvastatin #mg 38 Dissociation 38 WAITING FOR THE 38 multiple logistic regression 38 airway hyper responsiveness 38 % CI #.#-#.# [002] 38 total cholesterol LDL 38 albuminuria 38 DEGREE OF 38 RU EEU EUROPE ASIA 38 SEPARATION 38 Alanine 38 alanine transaminase 38 T1 hypointense lesions 38 GLUT4 38 subclinical atherosclerosis 38 Cardiogenic shock 38 CHANT 38 SECOND TERM 38 cells transfected 38 EP4 38 undetectable HBV DNA 38 RELATES TO 38 HOME LOANS 38 PROWESS 38 liver transaminases 38 n = 38 TRUST AND 38 IN PATIENTS WITH 38 HBV DNA 38 REVERSAL 38 HbA1c 38 REALISM 38 Subcutaneous 38 IGFBP 38 associated vasculitis 38 CLEANS UP 38 ABC/3TC 38 alanine aminotransferase ALT 38 Aß 38 GASTRIC 38 ADDRESS BY 38 FSH 38 achieved sustained virological 38 RATIONALE 38 postintervention 38 Angiotensin II 38 Intracranial 38 START WITH 38 DO NOT PLAY 38 CLINICAL TRIAL 38 PHRASE 38 serum PSA 38 HDL cholesterol HDL 38 macrophage inflammatory protein 38 deoxy 38 odds ratios ORs 38 POL PRO 38 NOT MISS 38 FDG-PET/CT 38 gm dl 38 CHOOSE YOUR 38 WINDOW OF 38 p = #.# [004] 38 microsomal 38 FROM BEYOND 38 Cardiotoxicity 38 immunoreactive 38 IRLS 38 neurologic deficits 38 adrenoceptor 38 bivalirudin monotherapy 38 colorectal adenoma 38 IPAH 38 REDUX 38 placebo p 38 AN EARLIER 38 Prognostic Value 38 hematologic toxicity 38 DIAGNOSTIC 38 ALTE 38 Intervention Trial 38 LOCKER 38 Pegylated Liposomal Doxorubicin 38 CARRYING THE 38 fluorodeoxyglucose 38 clinicopathological 38 VARY 38 protein tyrosine phosphatase 38 OUR CONSTITUTION 38 ACCEPT THE 38 Unified Parkinson Disease 38 noninferiority 38 c Fos 38 QRS duration 38 IQR 38 QVAR R 38 UNTIL FURTHER NOTICE 38 PATIENCE IS 38 BLOOD TEST 38 FLAIR 38 Elitek 38 immunostaining 38 μg ml 38 IGFBP 3 38 bone resorption 38 carboxylase 38 covariate 38 AUCs 38 MR Angiography 38 ghrelin agonist 38 ALT AST 38 CRITERIA 38 matrix metalloproteinase 38 glycosylated hemoglobin HbA1c 38 DUE FOR 38 hepatic insulin sensitivity 38 IIIb 38 gadolinium enhanced 38 serum lipid 38 serum triglyceride 38 irbesartan 38 Secondary endpoints included 38 % CI #.#-#.# [003] 38 GAME IS 38 Preoperatively 38 nanomolar 38 serum ferritin 38 EVALUATION 38 CONNECTION BETWEEN 38 SLOW TO 38 PLEASE BE 38 atherothrombotic 38 NO ORDINARY 38 sd = 38 #F FDG 38 cytologic 38 ALT elevation 38 NEED AN 38 mmol L. 38 PARKINSON 'S DISEASE 38 Chronic Obstructive Lung 37 TEQ 37 6 mercaptopurine 37 RU EUROPE EEU EMRG 37 DOCTRINE 37 aminotransferase levels 37 nondiabetic patients 37 lupus anticoagulant 37 Hemoglobin 37 SOX9 37 LDL triglycerides 37 MESSAGE FROM 37 PDSS 37 SIZE AND 37 recurrent venous thromboembolism 37 INDIRECT 37 Duodenal 37 EVALUATE 37 lipid abnormalities 37 TEST OF 37 TPV r 37 advanced neoplasia 37 K + ATPase 37 azacytidine 37 IOP lowering 37 rs# [004] 37 baseline LDH 37 THOMPSON CREEK METALS 37 HARD TO GET 37 LAPSE 37 subgroup analyzes 37 ORGANISE 37 serum calcium levels 37 STINGS 37 nonfatal myocardial infarction 37 DEPENDENCE 37 EXPECTATION 37 squamous intraepithelial lesions 37 SEEING THE 37 SCANS 37 effector memory 37 TSH 37 insulin degludec 37 Low Density Lipoprotein 37 leukotriene B4 37 PARTICIPATION 37 natriuretic peptide 37 Troponin T 37 noncardiac 37 lymphadenectomy 37 TGF beta1 37 BEARER 37 α 37 Clinical Relevance 37 mean ± SEM 37 treat NNT 37 DEFINITION 37 Hgb 37 UPSETTING 37 decitabine 37 FUNCTION 37 renal artery stenting 37 reticulocytes 37 WALK THROUGH 37 Pharmacokinetics PK 37 β = 37 ANCOVA 37 PlGF 37 biochemical recurrence 37 TC HDL 37 hemoglobin hematocrit 37 integrin alpha 37 PANEL ON 37 RAMP UP 37 liver transplant recipients 37 TDF FTC 37 intraabdominal 37 RESOLUTION NO 37 mU L 37 extracranial 37 reinfarction 37 mM 37 ≤ 37 normotensive 37 DETECTION 37 Sgk1 37 SUGGEST THAT 37 hematological parameters 37 QUERY 37 PATIENTS WHO 37 M1 muscarinic 37 CONVENIENT 37 DAS# [002] 37 Ultrasonography 37 VIRTUE 37 creatine kinase CK 37 TURBT 37 MATTER OF 37 RECIST criteria 37 INITIAL 37 ± 37 Beta Amyloid 37 lowest tertile 37 allelic variants 37 PCa 37 hepatic enzymes 37 OMITTED 37 PHILPOTT 37 TOTALLY DIFFERENT 37 GIVE HIM 37 ERalpha 37 SHARPER 37 CRY FOR 37 pathologic diagnosis 37 Tubulin 37 OPERATIVE 37 confidence intervals CIs 37 ENHANCEMENT 37 JMR Sunnex 37 Abeta# 37 histologically proven 37 myeloperoxidase MPO 37 multivariable Cox 37 PROCEED 37 p = NS 37 IIEF 37 serum TSH 37 iodixanol 37 annexin V 37 MAY CHANGE 37 ALIGNMENT 37 NOTHING WRONG 37 rapid virological response 37 Long Term Outcomes 37 Cinacalcet 37 Multivariate analysis 37 HGD 37 Alkaline Phosphatase 37 endoscopic ultrasonography 37 IFN α 37 lactate dehydrogenase 37 alagebrium 37 MARGIN OF 37 euthyroid 37 pegylated interferon alfa 2b 37 Relapsing Remitting Multiple Sclerosis 37 lipid accumulation 37 carotid artery thickness 37 STURM 37 LV systolic function 37 BRAWN 37 OFF YOUR 37 CONT 37 37 PAROLE BOARD 37 bleomycin 37 MALES 37 striatal 37 glucuronide 37 OBSERVED 37 androgen suppression 37 AND RECOMMENDATIONS 37 FAVOURED 37 nmol 37 REGAIN 37 Clinical Outcome 37 Skin sterol 37 VFQ 37 muscarinic receptors 37 DLTs 37 Radiation Dose 37 Partial Response 37 'S COMMENTS 37 PROPERTY FUND 37 efficacy endpoint 37 carboxypeptidase 37 acromegalic patients 37 cardiac allograft vasculopathy 37 HAVE AN 37 URGENCY 37 radiographic progression 37 plasma uric acid 37 -#.# ± [001] 37 NGAL 37 MIXED UP 37 Acute Myocardial Infarction 37 olmesartan 37 PIXEL 37 RETHINK 37 Annexin 37 BLACKED OUT 37 ON THEIR OWN 37 TRADITION OF 36 CLO RP 36 QUESTIONS ABOUT 36 ventricular dysfunction 36 -#.# log# 36 PLA2 36 glycated hemoglobin levels 36 subscales 36 TIPI 36 seropositivity 36 angiographically 36 FDG PET 36 ESTABLISH 36 CIBIC plus 36 seminal vesicle invasion 36 HCV antibody 36 urothelial carcinoma 36 MARGINAL 36 Asymptomatic 36 MORE EFFECTIVE 36 REALISTIC 36 INSPECT 36 F FLT 36 USAGE 36 detrusor overactivity 36 Evaluable 36 IS EVERYTHING 36 arterial thromboembolic events 36 TRIED AND 36 Visual acuity 36 pT2 36 cathepsin B 36 Cystatin C 36 WOMAC pain 36 Prostate specific antigen 36 nonoperative treatment 36 surrogate marker 36 mg BID dose 36 BUMBLE 36 IMPRESSION 36 STRESS AND 36 pulsatility index 36 HILLARY 'S 36 INDUCED 36 DELEGATE 36 HINTS 36 sirolimus eluting stents 36 Dual Antiplatelet Therapy 36 CONFIRM 36 LCX 36 ENTRANCE 36 PEDIATRIC 36 SNP rs# [002] 36 statistical significance p = 36 KDOQI 36 BATTLING FOR 36 stimulated insulin secretion 36 pmol 36 RESPOND TO 36 MICHIGAN 'S 36 MDQ 36 μM 36 fluorescein angiography 36 serum bicarbonate 36 PHASES 36 KILLIN 36 THEIR ACTIONS 36 mmHg p = 36 GIVING UP 36 prostate cancer CaP 36 Cronbach alpha 36 MIs 36 Novel Inhibitor 36 PSYCHOLOGICAL 36 noncardiovascular mortality 36 CAUSES OF 36 THEY CAN NOT 36 Hazard Ratio 36 Conclusions 36 #mg QD [002] 36 MR 36 DEPENDENT 36 hepatic 36 receptor blockers 36 aminotransferase ALT 36 mineralocorticoid receptor 36 TAX RATES 36 fibrinolysis 36 bile acid 36 BUDGETING 36 preoperative chemotherapy 36 Exenatide Byetta 36 sodium nitroprusside 36 THE BUBBLE 36 histone acetylation 36 MEDIATE 36 unfavorable cytogenetics 36 CsA 36 MOVEMENTS 36 ROTHENBERG 36 RELEVANCE 36 Posaconazole 36 pulmonary exacerbations 36 Bone Mineral Density 36 FUNCTIONING 36 CRAPPY